Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Emvenio Research
AddedFeb 15, 2024
UpdatedJun 18, 2026
Emvenio Research

Emvenio Research

Emvenio Research: Enhancing clinical trial access through decentralized solutions for high-risk populations.

HQ
Durham, NC, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Emvenio Research was founded with the mission to enhance clinical trial access by developing decentralized solutions that cater to underserved and high-risk populations. The company aims to eliminate barriers to clinical trials by bringing them directly to people where they live and work. Emvenio offers a range of services including community research sites, home and virtual visits, and patient engagement strategies. Their market focus is on diverse and underserved communities, ensuring that clinical research is more inclusive and accessible.

Notable affiliated individuals include experts in clinical research and community health, though specific names are not provided. Emvenio has garnered attention for its innovative approach to decentralizing clinical trials, significantly improving participation rates among high-risk populations. The company's impact is evident in its ability to bring clinical trials to local communities, thereby increasing diversity in research and accelerating the development of new treatments.

Emvenio Research - Similar Companies

Lightship logo

Lightship

lightship.com

MedVector logo

MedVector

medvector.com

Curavit Clinical Research logo

Curavit Clinical Research

SiteBridge Research logo

SiteBridge Research

ObvioHealth logo

ObvioHealth

obviohealth.com

Paradigm logo

Paradigm

paradigm.inc

RxE2 logo

RxE2

rxe2.com

SubjectWell logo

SubjectWell

subjectwell.com

Curebase logo

Curebase

curebase.com

Empirican Group logo

Empirican Group

empirican.com

Clinical Research IO logo

Clinical Research IO

Elligo Health Research logo

Elligo Health Research

High Enroll logo

High Enroll

highenroll.org

FindMeCure logo

FindMeCure

findmecure.com

Vitalief logo

Vitalief

vitalief.com

Emvenio Research - Quick Facts

Who are Emvenio Research's competitors?

Companies similar to Emvenio Research include Lightship, MedVector, Curavit Clinical Research and SiteBridge Research.

When was Emvenio Research founded?

Emvenio Research was founded in 2020.

Where is Emvenio Research's headquarters located?

Emvenio Research's headquarters is located in Durham, NC, US.

When was Emvenio Research's last funding round?

Emvenio Research's most recent funding round was for $9.2M (USD) in August 2022.

How much has Emvenio Research raised to-date?

As of Aug 24, 2022, Emvenio Research has raised a total of $9.2M (USD).

How many employees does Emvenio Research have?

Emvenio Research has 52 employees as of Feb 5, 2024.

Emvenio Research - Classification

Industry
  • Professional Service Companies
Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Clinical Trials
Tags
  • Consulting
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified